Open Access

[Corrigendum] What is considered cardiotoxicity of anthracyclines in animal studies

  • Authors:
    • Nikolaos Georgiadis
    • Konstantinos Tsarouhas
    • Ramin Rezaee
    • Haritini Nepka
    • George E.N. Kass
    • Jean‑Lou C.M. Dorne
    • Dimitrios Stagos
    • Konstantinos Toutouzas
    • Demetrios A. Spandidos
    • Dimitrios Kouretas
    • Christina Tsitsimpikou
  • View Affiliations

  • Published online on: August 6, 2020     https://doi.org/10.3892/or.2020.7717
  • Pages: 1772-1772
  • Copyright : © Georgiadis et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Related Articles

Journal Cover

October-2020
Volume 44 Issue 4

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Georgiadis N, Tsarouhas K, Rezaee R, Nepka H, Kass GE, Dorne JLC, Stagos D, Toutouzas K, Spandidos DA, Kouretas D, Kouretas D, et al: [Corrigendum] What is considered cardiotoxicity of anthracyclines in animal studies. Oncol Rep 44: 1772-1772, 2020
APA
Georgiadis, N., Tsarouhas, K., Rezaee, R., Nepka, H., Kass, G.E., Dorne, J.C. ... Tsitsimpikou, C. (2020). [Corrigendum] What is considered cardiotoxicity of anthracyclines in animal studies. Oncology Reports, 44, 1772-1772. https://doi.org/10.3892/or.2020.7717
MLA
Georgiadis, N., Tsarouhas, K., Rezaee, R., Nepka, H., Kass, G. E., Dorne, J. C., Stagos, D., Toutouzas, K., Spandidos, D. A., Kouretas, D., Tsitsimpikou, C."[Corrigendum] What is considered cardiotoxicity of anthracyclines in animal studies". Oncology Reports 44.4 (2020): 1772-1772.
Chicago
Georgiadis, N., Tsarouhas, K., Rezaee, R., Nepka, H., Kass, G. E., Dorne, J. C., Stagos, D., Toutouzas, K., Spandidos, D. A., Kouretas, D., Tsitsimpikou, C."[Corrigendum] What is considered cardiotoxicity of anthracyclines in animal studies". Oncology Reports 44, no. 4 (2020): 1772-1772. https://doi.org/10.3892/or.2020.7717